Australia's most trusted
source of pharma news
Wednesday, 12 March 2025
Posted 11 March 2025 PM
After masterminding a massive company-wide restructure which came with thousands of global job losses, Bayer CEO Bill Anderson is also feeling the pinch, seeing his pay packet shrink.
Last year, his total compensation package dropped more than 20 per cent year-on-year to AU$15.1 million (8.84 million euros), down from $19.3 million (11.24 million euros).
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.